Market Knowledge and Stakeholder Considerations for the Biopharmaceutics Sector—Incorporating User Value and Societal Needs in Therapeutic Interventions

Timmis, James Kenneth; Waal, Raymond X. van der; Herz, Jennifer; Waal, Mark B. van der; Claassen, Eric; Burgwal, Linda van de

doi:10.4236/health.2021.1311099

Cited by 3 publications

(2 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Second, determine the investment recovery of enterprise digital information technology, and make statistics on the investment recovery rate every month, so as to evaluate the investment recovery period and judge the investment recovery period [27]. e calculation formula for investment recovery rate is as follows:…”

Section: Economic Evaluation Of Digital Informatizationmentioning

confidence: 99%

Application of Digital Information Technology in Enterprise Innovation Management

Zhang

Chi

2022

Mobile Information Systems

View full text Add to dashboard Cite

Digital information technology is the key to realize the efficient management of enterprises. It is necessary to analyze the information technology and provide perfect operating conditions for enterprises in combination with the economic management of enterprises. This article studies enterprise management in the digital information environment, improves the effectiveness of enterprise management methods, and judges the management state of enterprises. At the same time, formula calculation is used to provide a test method for the application effect of digital information technology so that that information technology can be evaluated fairly. The experimental results show that enterprise management also involves inventory management. It is necessary to use information technology to identify products, record the process of products entering and leaving the warehouse in combination with code scanning technology, and optimize the product management process. In the process of enterprise management, the process management form should be adopted to improve the reliability of management methods and ensure that the enterprise has a normal management mode and perfection of enterprise operation state. It proves that digital information technology can promote the development of enterprises, improve the reliability of enterprise management, and reduce the impact of adverse factors on enterprises.

show abstract

Section: Economic Evaluation Of Digital Informatizationmentioning

confidence: 99%

Application of Digital Information Technology in Enterprise Innovation Management

Zhang

Chi

2022

Mobile Information Systems

View full text Add to dashboard Cite

show abstract

“…In addition, including patent information early in the R&D process can improve focus of R&D efforts (and thereby prevent ‘reinventing the wheel’), and incentivise organisations to address hitherto unsolved technical challenges, or improve existing technologies. While commercial parties might focus on competitor or market analysis, public parties, such as policy makers, funding agencies and academia, will likely be more interested in economic performance and societal impact (Bonino et al, 2010; Bubela et al, 2013; Cordaillat‐Simmons et al, 2020; Timmis et al, 2021; Trajtenberg & Jaffe, 2002; Trippe, 2015).…”

Section: Introductionmentioning

confidence: 99%

Patent landscape analysis—Contributing to the identification of technology trends and informing research and innovation funding policy

Rijn

Timmis

2023

Microbial Biotechnology

View full text Add to dashboard Cite

Patents and the systematic analysis thereof provide important decision information for a range of stakeholders pursuing diverse goals. However, in particular academia and small‐scale private sector innovators underappreciate the value of patent information for identifying research gaps, ensuring originality of their work and, in turn, maximisation of limited (public) funds. By the same token, pertinent public sector organisations, such as regulators, require overviews of potentially upcoming technologies to adequately adapt regulatory protocols. The latter, in particular if contemporary scientific evidence is not sufficient, can require a substantial amount of time and lead to a delay in the marketing of important innovations. Patent landscape analysis (PLA) is a very useful method to create overviews of technology fields and thereby indicate if, inter alia, a specific line of scientific enquiry and its application have already been pursued or potential regulatory gaps will exist in the near‐ to mid‐term future. The objective of this communication is to increase awareness of the utility of patent information and provide support in retrieval and analysis of pertinent information for those involved in biotech R&D. Based on Espacenet, a patent search engine, we provide basic guidance on search strategy development, piloting and execution, and data preparation and analysis. To highlight the value of PLA, we also summarise selected results of a PLA we performed recently for microbiome targeting interventions, also referred to as live biotherapeutic products.

show abstract

Innovations for microbiome targeting interventions – a patent landscape analysis indicating overall patenting activity decline and promising target disease areas

Timmis

Roussilhon

Burgwal

2022

View full text Add to dashboard Cite

The human microbiota have been implicated in the aetiology and remedy of a host of disorders. However, due to the pervasive uncertainty inherent in the field of microbiota-targeting interventions and associated issues with establishing rigorous safety and efficacy profiles, regulatory oversight is suboptimal. This can dissuade innovators from further exploring novel and much needed health interventions. Modification of regulatory protocols and practices requires focussed efforts and funding to build the evidence base around future regulatory needs. Such modification can be critically informed by identification of changes and trends in technology fields to facilitate identification of regulatory gaps. To this purpose, this study rigorously collected and analysed patent data from Espacenet – covering the years 2013-2018 – and created a patent landscape analysis of microbiome targeting interventions with a focus on medicinal products. Pertinent patenting activity has declined overall. While, in absolute terms, patents most frequently claimed inventions targeting disorders of the gut and alimentary tract, relative year-on-year interest increases have been substantial for cancer, and disorders of the (neuro-)muscular and respiratory systems – driven by the private sector. Academic stakeholders showed top interest in disorders of the metabolism, anti-infectives, and skeletal and dermatological diseases. Although medicinal preparation claims dominated our dataset, a third of patents claimed food preparations, while only 1% claimed application as a diagnostic. Finally, China is, by an inordinate margin, a market of particular interest for both domestic and foreign innovators, indicating that microbiome targeting intervention innovation for EU and US markets might be frustrated. This study is the first to empirically demonstrate that live biotherapeutic product innovation is decelerating and potentially frustrated, supporting the urgent need for improved regulatory standards. Our results indicate which disease areas deserve particular attention for research funding to facilitate proper regulatory appraisal in the near- to mid-term future

show abstract

Market Knowledge and Stakeholder Considerations for the Biopharmaceutics Sector—Incorporating User Value and Societal Needs in Therapeutic Interventions

Cited by 3 publications

References 34 publications

Application of Digital Information Technology in Enterprise Innovation Management

Application of Digital Information Technology in Enterprise Innovation Management

Patent landscape analysis—Contributing to the identification of technology trends and informing research and innovation funding policy

Innovations for microbiome targeting interventions – a patent landscape analysis indicating overall patenting activity decline and promising target disease areas

Contact Info

Product

Resources

About